RECRUITING

Parkinson Progression Marker Initiative Online (PPMI Online)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal of better understanding risk and predictive factors for PD. PPMI Online is part of the broader Parkinson Progression Marker Initiative aimed at identifying markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.

Official Title

Parkinson's Progression Markers Initiative Online Study (PPMI Online)

Quick Facts

Study Start:2021-07-28
Study Completion:2041-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05065060

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Parkinson Disease (PD) Participants:
  2. * Male or female age 18 years or older.
  3. * Has received a diagnosis of Parkinson's disease
  4. * Male or female age 18 years or older.
  5. * Has not received a diagnosis of Parkinson's disease
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

University of California, San Francisco
CONTACT
877-525-7764
info@ppmionline.org

Principal Investigator

Caroline Tanner, MD, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Kenneth L Marek, MD
PRINCIPAL_INVESTIGATOR
Institute for Neurodegenerative Disorders

Study Locations (Sites)

UCSF Movement Disorders and Neuromodulation Center (MDNC)
San Francisco, California, 94143
United States

Collaborators and Investigators

Sponsor: Michael J. Fox Foundation for Parkinson's Research

  • Caroline Tanner, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • Kenneth L Marek, MD, PRINCIPAL_INVESTIGATOR, Institute for Neurodegenerative Disorders

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-28
Study Completion Date2041-12

Study Record Updates

Study Start Date2021-07-28
Study Completion Date2041-12

Terms related to this study

Keywords Provided by Researchers

  • Parkinson
  • Neurodegenerative Disorder
  • Prodromal
  • At Risk
  • Participant Reported Outcomes

Additional Relevant MeSH Terms

  • Parkinson Disease